This Article Full Text Full Text (PDF) All Versions of this Article: 36/3/533    most recent 01.STR.0000155741.31499.c2v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Pezzini, A. Articles by Padovani, A. Search for Related Content PubMed PubMed Citation Articles by Pezzini, A. Articles by Padovani, A. Related Collections Clinical genetics Cerebrovascular disease/stroke Genetics of Stroke Epidemiology Genetics of cardiovascular disease

(Stroke. 2005;36:533.)
© 2005 American Heart Association, Inc.

Original Contributions

Cumulative Effect of Predisposing Genotypes and Their Interaction With Modifiable Factors on the Risk of Ischemic Stroke in Young Adults

Alessandro Pezzini, MD; Mario Grassi, PhD; Elisabetta Del Zotto, MD; Silvana Archetti, PhD; Raffaella Spezi, MD; Veronica Vergani, MD; Deodato Assanelli, MD; Luigi Caimi, MD Alessandro Padovani, MD, PhD

From Clinica Neurologica (A.P., E.D.Z., R.S., V.V., A.P.), Università degli Studi di Brescia, Brescia, Italia; the Dipartimento di Scienze Sanitarie Applicate (M.G.), Sezione di Statistica Medica ed Epidemiologia, Università degli Studi di Pavia, Pavia, Italia; III Laboratorio di Analisi (S.A.), Biotecnologie, Università degli Studi di Brescia, Brescia, Italia; the Dipartimento di Scienze Mediche e Chirurgiche (D.A.), Università degli Studi di Brescia, Brescia, Italia; and the Dipartimento di Biochimica (L.C.), Università degli Studi di Brescia, Brescia, Italia.

Correspondence to Dr Alessandro Pezzini, Clinica Neurologica, Università degli Studi di Brescia, P.le Spedali Civili, 1, 25100 Brescia, Italia. E-mail ale_pezzini{at}hotmail.com

Background and Purpose— Combinations of multiple predisposing polymorphisms and their interactions with modifiable factors may result in synergistic effects on the risk of ischemic stroke. These mechanisms are more likely to play a relevant role in younger individuals.

Methods— The cumulative effect of the 20210A variant of prothrombin gene, the 1691A variant of factor V gene, the TT677 genotype of the methylenetetrahydrofolate reductase (MTHFR) gene, and the 4-carriership of the apolipoprotein (APOE) gene, as well as their interactions with modifiable predisposing factors, were determined in a series of 163 stroke patients aged younger than 45 years and 158 controls.

Results— Odds ratios (ORs) for stroke were 1.73 (95% confidence interval [CI], 1.20 to 2.51) in subjects with 1 polymorphism and 3.00 (95% CI, 1.43 to 6.30) in those with 2. Compared with nonsmokers with none of the studied polymorphisms, ORs for stroke were 1.88 (95% CI, 1.18 to 3.00) and 3.55 (95% CI, 1.40 to 8.98) for nonsmokers with 1 and 2 polymorphisms, respectively, and 3.99 (95% CI, 2.00 to 7.96) and 15.99 (95% CI, 4.01 to 63.3) for smokers. Compared with nonhypertensive subjects bearing no polymorphisms, ORs were 1.91 (95% CI, 1.28 to 2.87) and 3.68 (95% CI, 1.64 to 8.26) for nonhypertensive subjects with 1 and 2 polymorphisms, 3.28 (95% CI, 1.01 to 10.7) and 10.79 (95% CI, 1.01 to 115.4) for hypertensive.

Conclusions— These data suggest a gene–dose effect of the examined prothrombotic and proatherogenic gene variants and a synergistic effect of these polymorphisms and modifiable risk factors in the pathogenesis of cerebral ischemia in young adults.

Key Words: genetics • risk factors • stroke, ischemic